# Advances and Challenges in Obstetric Intensive Care Medicine

**Authors:** Antonio Braga, Helder Konrad De Melo, Gabriela Paiva, Gustavo Mourão Rodrigues, Gustavo Yano Callado, Edward Araujo Júnior, Joffre Amim-Junior, Jorge de Rezende-Filho, Roberta Granese

PMC · DOI: 10.3390/jcm15041487 · 2026-02-13

## TL;DR

This review discusses the challenges and strategies in managing critically ill pregnant and postpartum women, emphasizing maternal-fetal care and multidisciplinary collaboration.

## Contribution

The paper provides a comprehensive overview of obstetric intensive care, integrating physiological, ethical, and organizational considerations.

## Key findings

- Maternal physiological adaptations can mask early signs of deterioration, leading to rapid critical illness.
- Structured early warning systems and point-of-care ultrasonography are vital for detecting clinical deterioration.
- Maternal stabilization is the primary factor influencing fetal outcomes in critical care.

## Abstract

Obstetric critical care encompasses the management of pregnant and postpartum women with life-threatening conditions, requiring integration of intensive care principles with pregnancy-specific physiological, ethical, and organizational considerations. Although pregnancy is a physiological state, profound maternal adaptations may mask early signs of clinical deterioration, allowing rapid progression to a critical illness condition. This review provides a comprehensive overview of the foundations of obstetric intensive care, addressing maternal–fetal physiology, recognition of severity, organ support strategies, and contemporary models of care. Key aspects discussed include cardiovascular, respiratory, renal, and hematological adaptations of pregnancy; principles of airway management and mechanical ventilation; hemodynamic support; transfusion strategies guided by viscoelastic testing; renal replacement therapy; extracorporeal support, including extracorporeal membrane oxygenation and cardiopulmonary bypass; and the safe use of diagnostic imaging involving ionizing radiation. The role of point-of-care ultrasonography, structured early warning systems, and advanced monitoring in early detection and management of clinical deterioration is emphasized. Special attention is given to maternal–fetal interactions, fetal monitoring in the intensive care unit (ICU), and complex decision-making regarding timing and mode of delivery. The review also highlights the importance of multidisciplinary and multiprofessional collaboration, ethical challenges inherent to dual-patient care, and emerging strategies to expand access to specialized care, including tele–ICU models and artificial intelligence–assisted surveillance. Across all scenarios, maternal stabilization remains the primary determinant of fetal outcome. A structured approach grounded in maternal–fetal physiology and ethical principles is essential to reduce preventable maternal and perinatal morbidity and mortality in high-complexity settings.

## Full-text entities

- **Genes:** CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}
- **Diseases:** septic (MESH:D001170), ketosis (MESH:D007662), ARDS (MESH:D012128), PTSD (MESH:D013313), magnesium disturbances (MESH:D008275), pulmonary embolism (MESH:D011655), maternal disease (MESH:D000079262), hematologic, cardiovascular, renal, and neurologic dysfunction (MESH:D009461), malformation (MESH:C564254), hypotension (MESH:D007022), bowel ischemia (MESH:D007511), chorioamnionitis (MESH:D002821), acute abdomen (MESH:D000006), severe acute respiratory distress syndrome (MESH:D045169), tamponade (MESH:D002305), SOS (MESH:D018805), pulmonary hypertension (MESH:D006976), impaired concentration (MESH:C567712), bradycardia (MESH:D001919), respiratory/metabolic acidosis (MESH:D000142), Infectious disease (MESH:D003141), memory deficits (MESH:D008569), fibrinogen deficiency (MESH:D000347), placental abruption (MESH:D000037), hypoxemia (MESH:D000860), vomiting (MESH:D014839), pericardial effusion (MESH:D010490), disseminated intravascular coagulation (MESH:D004211), systemic lupus erythematosus (MESH:D008180), bonding disorders (MESH:D009358), fetal distress (MESH:D005316), pregnancy loss (MESH:D000022), respiratory alkalosis (MESH:D000472), Organ Failure (MESH:D009102), cardiac failure (MESH:D006333), congenital lesions (MESH:D009059), Arrhythmia (MESH:D001145), structural dysfunction (MESH:D020914), Tachycardia (MESH:D013610), glomerular diseases (MESH:D007674), infective endocarditis (MESH:D004696), acute fatty liver of pregnancy (MESH:C537957), obesity (MESH:D009765), Hemorrhagic (MESH:D006470), depression (MESH:D003866), embolism (MESH:D004617), laryngeal edema (MESH:D007819), acute respiratory failure (MESH:D012131), intracranial hemorrhage (MESH:D020300), weight gain (MESH:D015430), torsades (MESH:D016171), AI (MESH:C538142), hypocapnia (MESH:D016857), postpartum (MESH:D006473), stroke (MESH:D020521), Acute kidney injury (MESH:D058186), hypercoagulable (MESH:D019851), hypercapnia (MESH:D006935), ileus (MESH:D045823), fetal (MESH:D005315)
- **Chemicals:** progesterone (MESH:D011374), norepinephrine (MESH:D009638), calcium (MESH:D002118), creatinine (MESH:D003404), glucose (MESH:D005947), magnesium (MESH:D008274), CO2 (MESH:D002245), tranexamic acid (MESH:D014148), amiodarone (MESH:D000638), water (MESH:D014867), Gadolinium (MESH:D005682), iodine (MESH:D007455), nitrogen (MESH:D009584), magnesium sulfate (MESH:D008278), beta-lactam antibiotics (MESH:D008997), carbohydrate (MESH:D002241), epinephrine (MESH:D004837), ketone (MESH:D007659), oxytocin (MESH:D010121), Bohr (-), Oxygen (MESH:D010100), sodium (MESH:D012964), sodium citrate (MESH:D000077559), phosphate (MESH:D010710), potassium (MESH:D011188)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12941451